Simponi and Hair loss - a phase IV clinical study of FDA data
Summary:
We study 78,881 people who have side effects when taking Simponi. Hair loss is found, especially among people who are female, 40-49 old, have been taking the drug for 1 - 6 months, also take Orencia and have Psoriatic arthropathy.
The phase IV clinical study analyzes which people take Simponi and have Hair loss. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
78,881 people reported to have side effects when taking Simponi.
Among them, 9,850 people (12.49%) have Hair loss.
What is Simponi?
Simponi has active ingredients of golimumab. It is used in rheumatoid arthritis. Currently, eHealthMe is studying from 79,099 Simponi users.
What is Hair loss?
Hair loss is found to be associated with 3,576 drugs and 3,391 conditions by eHealthMe. Currently, we are studying 258,035 people who have Hair loss.
Number of Simponi and Hair loss reports submitted per year:
Time on Simponi when people have Hair loss *:
Gender of people who have Hair loss when taking Simponi*:
Age of people who have Hair loss when taking Simponi *:
Common drugs people take besides Simponi *:
Common side effects people have besides Hair loss *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Simponi and have Hair loss?
Check whether Hair loss is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Azuma N, Matsui K, Hashimoto N, Yoshikawa T, Sano H, "Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis", Internal Medicine, 2017 Jun .
- Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .
Related studies
Simponi side effects by duration, gender and age:
- Simponi side effects (79,099 reports)
Hair loss treatments and more:
- Hair loss (258,035 reports)
Common drugs associated with Hair loss:
- Taxotere: 34,064 reports
- Docetaxel: 25,062 reports
- Methotrexate: 19,713 reports
- Prednisone: 16,883 reports
- Humira: 14,833 reports
- Enbrel: 14,300 reports
- Remicade: 12,381 reports
- Neosar: 12,108 reports
- Orencia: 11,906 reports
- Simponi: 9,850 reports
All the drugs that are associated with Hair loss:
- Hair loss (3,576 drugs)
Common conditions associated with Hair loss:
- Rheumatoid arthritis: 21,741 reports
- Multiple sclerosis: 14,215 reports
- Breast cancer: 11,443 reports
- Chemotherapy: 8,910 reports
- High blood pressure: 5,484 reports
All the conditions that are associated with Hair loss:
- Hair loss (3,391 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on golimumab (the active ingredients of Simponi) and Simponi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Mirtazapine and Claravis drug interaction - 9 seconds ago
- Reclast and Sinusitis - Acute - 33 seconds ago
- Reclast and Sinusitis - 33 seconds ago
- Erbitux and Cholestasis - 44 seconds ago
- Dexamethasone and Keratomileusis - 50 seconds ago
- Allegra and Briviact drug interaction - 55 seconds ago
- Everolimus and Fluorouracil drug interaction - a minute ago
- Vitamin K and Oncovin drug interaction - a minute ago
- Silvadene and Escitalopram drug interaction - a minute ago
- Meloxicam and Idhifa drug interaction - a minute ago